SBIR/STTR Research Award

Stabilization of Enzymes for the Destruction of Toxic Materials and Chemical Agents

Award identifier d6f6e4f83f8131c237960c3417251128d9a6d4e1e41561693dfbc363377cfd47Awarding agency Department of Defense · Army

Award amount

$69,915

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
Eikos, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
X2J1C6N7K4A6
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Eikos will exploit the power of microarray technology to rapidly identify and isolate a wide variety of ultra-stable organophosphorous anhydrolases (OPA's) to formulate an enzyme cocktail capable of decontaminating OP nerve and blistering agents across aspectrum of temperatures and pH's without loss of activity or denaturation. Extremozymes (enzymes isolated from extremophiles) are infinitely more active and less susceptible to denaturation in traditionally inhospitable environments such as non-neutralpH, oxidizing conditions, and high and low temperatures. Therefore, these enzymes are ideally suited for enzymatic catalysis in the field. The arduous task of isolating such enzymes has precluded their widespread use in industrial catalysis. Theemergence of microarray technology has made it possible to quickly and efficiently screen an enormous number of organisms for any activity of interest. Eikos will fabricate an OPA specific microarray and screen multiple extremophilic organisms for thepresence of detoxifying enzymes. Genetic information determined with the microarray will then be used to swiftly isolate each enzyme. A collection of enzymes collected in this manner will possess the catalytic ability to detoxify OP nerve and blisteringagents in almost any environment. The combination of microarray technology and extraordinary extremozyme stability will revolutionize industrial enzymatic catalysis.An extremophile array will be capable of screening for not only OPAs, but alsopolymerases, proteases, restriction enzymes, etc. and will find utility in commercial and industrial markets. Industrial enzymes represent a $2 billion annual market. Most notable markets include detergents manufacturing with a vested interest in hightemperature proteases, environmental chemistry interested in bioremediation, the pharmaceutical industry interested in novel natural product synthesis, and energy related fields interested in the natural gas production of many extremophilic bacteria.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

48 SBIR/STTR records share this UEI (1997–2014). Reported award amounts total $12,797,408. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, National Science Foundation, Department of Commerce

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.